$0.25
0.00 (0%)
TorreyPines Therapeutics, Inc. (TPTX)
CAPS Rating:
A biopharmaceutical company, committed to the discovery, development and commercialization of novel small molecules to treat diseases and disorders of the central nervous system.
No one has written a Pitch for TPTX stock yet. Tell us why you think TPTX will outperform or underperform the S&P 500.
RSS Headlines
Fool UK
